三甲基-(1-吩噻嗪-10-基丙-2-基)铵 | 2338-21-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻嗪类
• 中文名称: 三甲基-(1-吩噻嗪-10-基丙-2-基)铵
• 英文名称: Thiazinamium
• 英文别名: trimethyl(1-phenothiazin-10-ylpropan-2-yl)azanium
• CAS: 2338-21-8
• 化学式: C18H23N2S+
• 分子量: 299.5
• InChiKey: CDXCCYNINPIWGE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  28.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Unsaturated polyester resin system for cured in-place piping
  申请人：Interplastic Corporation

  公开号：US10131766B2

  公开（公告）日：2018-11-20

  A process to use an unsaturated polyester resin system comprising preparing a curable cumene-quat curing system. The cumene-quat curing system can comprise an unsaturated polyester resin, a peroxide initiator, a quaternary ammonium salt component, a 2,4-pentanedione component, and an inhibitor component. The peroxide initiator can comprise a cumene hydroperoxide component. The process can further comprise applying the curable cumene-quat curing system in a cured-in-place pipe rehabilitation process.

  一种使用不饱和聚酯树脂体系的工艺，包括制备可固化的积烯-夸特固化体系。积烯-夸特固化体系可包括不饱和聚酯树脂、过氧化物引发剂、季铵盐成分、2,4-戊二酮成分和抑制剂成分。过氧化物引发剂可包括过氧化氢积炭成分。该工艺还包括在就地固化管道修复工艺中应用可固化的积烯-夸特固化体系。
• Extended relief dosage form
  申请人：The Procter & Gamble Company

  公开号：US10576041B2

  公开（公告）日：2020-03-03

  A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.

  一种具有第一部分和第二部分的剂型。第一部分可以是速释部分，包含一种止痛剂，可以是萘普生或萘普生钠。第二部分可以是缓释部分，可以包括伪麻黄碱或其药学上可接受的盐和/或右美沙芬或其药学上可接受的盐。该剂型可选择包含一种稳定剂。该剂型可使止痛剂、伪麻黄碱或其药学上可接受的盐和/或右美沙芬或其药学上可接受的盐的治疗有效量维持至少八小时。
• Compositions and methods for the treatment of pain
  申请人：GM Pharmaceuticals, Inc.

  公开号：US10987365B2

  公开（公告）日：2021-04-27

  The claimed invention relates to compositions that may be in a form of a liquid, solid, gel, cream or gel capsule comprising an analgesic, and methods for administering these compositions for treatment of patients suffering from various forms of pain.

  本发明涉及可为液体、固体、凝胶、乳膏或凝胶胶囊形式的包含镇痛剂的组合物，以及使用这些组合物治疗各种形式疼痛患者的方法。
• PHARMACEUTICAL COMPOSITIONS INCLUDING AN ANTIHISTAMINE AND A STIMULANT AND USE THEREOF
  申请人：Pediamed Pharmaceuticals, Inc.

  公开号：EP1641446A1

  公开（公告）日：2006-04-05
• POLYMERS CONTAINING HEAT LABILE COMPONENTS ADSORBED ON POLYMERIC CARRIERS AND METHODS FOR THEIR PREPARATION
  申请人：Fosco, Frank, M., Jr.

  公开号：EP2731428A2

  公开（公告）日：2014-05-21